FDA Inspection 1092612 — Department Of Defense - Navy (U.S. Naval Hospital Sigonella)
The FDA completed an inspection of Department Of Defense - Navy (U.S. Naval Hospital Sigonella) on May 3, 2019 in Sigonella. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- May 3, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Sigonella (Italy)